Alignment Healthcare (NASDAQ:ALHC) Insider Sells $214,080.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 12,000 shares of the stock in a transaction dated Wednesday, March 18th. The stock was sold at an average price of $17.84, for a total value of $214,080.00. Following the transaction, the insider owned 160,230 shares of the company’s stock, valued at approximately $2,858,503.20. This trade represents a 6.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

Alignment Healthcare Stock Down 0.2%

Shares of Alignment Healthcare stock traded down $0.03 during trading on Thursday, reaching $18.16. The stock had a trading volume of 3,987,587 shares, compared to its average volume of 2,967,147. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.80. The company has a market capitalization of $3.71 billion, a price-to-earnings ratio of -1,814.19, a P/E/G ratio of 2.62 and a beta of 1.18. The stock has a fifty day moving average price of $20.57 and a two-hundred day moving average price of $18.78. Alignment Healthcare, Inc. has a 52 week low of $11.63 and a 52 week high of $23.87.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings data on Thursday, February 26th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.10. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. During the same period last year, the company earned ($0.16) earnings per share. Alignment Healthcare’s quarterly revenue was up 44.4% on a year-over-year basis. Sell-side analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. TD Cowen lifted their price objective on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. JPMorgan Chase & Co. raised their target price on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. UBS Group lifted their price target on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, January 14th. Robert W. Baird set a $28.00 price target on shares of Alignment Healthcare in a research report on Friday, January 30th. Finally, Piper Sandler increased their price objective on shares of Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $24.56.

Institutional Trading of Alignment Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wellington Management Group LLP grew its position in shares of Alignment Healthcare by 167.3% in the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company’s stock valued at $193,516,000 after acquiring an additional 6,940,277 shares during the period. Invesco Ltd. lifted its stake in Alignment Healthcare by 122.3% in the 2nd quarter. Invesco Ltd. now owns 4,170,529 shares of the company’s stock valued at $58,387,000 after purchasing an additional 2,294,739 shares during the last quarter. Capital World Investors acquired a new stake in Alignment Healthcare in the 4th quarter valued at about $44,203,000. Loomis Sayles & Co. L P bought a new position in Alignment Healthcare during the fourth quarter worth about $44,162,000. Finally, Danica Pension Livsforsikringsaktieselskab bought a new position in Alignment Healthcare during the fourth quarter worth about $39,500,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.